Exploiting dendritic cells for active immunotherapy of cancer and chronic infection

Methods Mol Med. 2005:109:1-18.

Abstract

Dendritic cells (DC) are important antigen-presenting cells (APC) that can prime naive T-cells and control lymphocyte-mediated adaptive immune responses with respect to magnitude, memory, and self-tolerance. Understanding the biology of these cells is central to the development of new generation immunotherapies for cancer and chronic infection. This chapter presents a brief overview of DC biology and the preparation and use of DC-based vaccines.

Publication types

  • Review

MeSH terms

  • Animals
  • Antigen Presentation / immunology
  • Dendritic Cells / cytology
  • Dendritic Cells / immunology*
  • Humans
  • Immunotherapy, Active / methods*
  • Infections / immunology*
  • Infections / therapy*
  • Lymphocyte Activation / immunology
  • Neoplasms / immunology*
  • Neoplasms / therapy*